Axitinib in combination with pembrolizumab in patients with advanced renal cell cancer: a non-randomised, open-label, dose-finding, and dose-expansion phase 1b trial. (Q50030031)
Jump to navigation
Jump to search
scientific article published on 9 February 2018
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Axitinib in combination with pembrolizumab in patients with advanced renal cell cancer: a non-randomised, open-label, dose-finding, and dose-expansion phase 1b trial. |
scientific article published on 9 February 2018 |
Statements
1 reference
Axitinib in combination with pembrolizumab in patients with advanced renal cell cancer: a non-randomised, open-label, dose-finding, and dose-expansion phase 1b trial (English)
Michael B Atkins
Elizabeth R Plimack
Igor Puzanov
Mayer N Fishman
David F McDermott
Daniel C Cho
Saby George
Thomas E Olencki
Jamal C Tarazi
Brad Rosbrook
Kathrine C Fernandez
Mariajose Lechuga
9 February 2018
1 reference